Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 3Recruiting 3Unknown 2Completed 2Suspended 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 2Sarcoma 1Plasma cell 1Breast 1

Conditions

Lymphoma 335Precursor Cell Lymphoblastic Leukemia-Lymphoma 292Lymphoma, Large B-Cell, Diffuse 216Lymphoma, Non-Hodgkin 192Lymphoma, Follicular 172Leukemia, Lymphocytic, Chronic, B-Cell 129Lymphoma, B-Cell 123Hodgkin Disease 112Leukemia 104Recurrence 100Lymphoma, Mantle-Cell 89Burkitt Lymphoma 88Lymphoma, T-Cell, Peripheral 60Lymphoma, Extranodal NK-T-Cell 56Multiple Myeloma 53Leukemia, Myeloid, Acute 53Lymphoma, B-Cell, Marginal Zone 51Lymphoma, T-Cell 41Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 39Neoplasms 39Leukemia, B-Cell 39Lymphoma, T-Cell, Cutaneous 37Lymphoma, Large-Cell, Immunoblastic 31Myelodysplastic Syndromes 30Hematologic Neoplasms 25Mycosis Fungoides 24Lymphoma, Large-Cell, Anaplastic 24Neoplasms, Plasma Cell 23Waldenstrom Macroglobulinemia 22Immunoblastic Lymphadenopathy 22

Interventions

Diagnostic Tests, Routine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Castleman Disease × Lymphoid × Clear all
NCT05081141 2024-05-07

HHV8 and Solid Organ Transplantation

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Unknown
250 enrolled
LymphoidSarcoma

Castleman Disease, Sarcoma, Kaposi

NCT00891280 2011-06-15

Dose-escalation Study of Oral CX-4945

Cylene Pharmaceuticals

Phase 1 Unknown
55 enrolled
BreastLymphoidPlasma cell

Breast Neoplasms, Castleman Disease, Multiple Myeloma, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡